Weekly Top Stories: Mental Health Experts Call for Urgent Improvement in Public Accessibility
This week, Canada’s healthcare landscape saw a major policy shift alongside growing concerns about mental health accessibility and outcomes. Bill C-64, the Pharmacare Act, has reached a crucial milestone, receiving Royal Assent from the Governor General of Canada on October 10, 2024, following its third Senate reading. The Act, which will come into effect once the House of Commons Chamber is notified, marks a significant step towards a national universal pharmacare plan. It will initially cover diabetes and birth control medications, allowing the federal government to forge agreements with provinces and territories to incorporate these medications into the public health system. Health Minister Mark Holland, who sponsored the bill, is set to collaborate closely with provinces and territories in deciding bilateral agreements for universal and single-payer first-dollar coverage for medications as part of the first phase of the pharmacare program. British Columbia has already signed a memorandum of understanding with the federal government to launch the same program in the province. Notably, the bill was central to the political pact between the Liberals and the New Democratic Party (NDP). The NDP, however, ended the two-and-a-half-year supply-and-confidence agreement with Prime Minister Justin Trudeau’s party last September 4, 2024. While the Pharmacare Act represents progress in medication coverage, mental health experts are urgently calling for improved public accessibility to health services in Canada, as various reports highlight significant gaps in the current system. The Canadian Institute for Health Information reported that Canadians’ health is significantly affected by economic factors, citing a negative impact on their mental health due to financial concerns. The financial barrier between the public and mental healthcare also affects Canadians daily. This includes the lack of access to psychotherapy and counselling due to the exclusion of it from the country’s public healthcare system. Elisabeth Briere, in an opinion piece, emphasizes the need for accessible and inclusive mental health services, particularly for youth, as one-third of girls aged 16 to 21 are more prone to experience a decline in their mental health. The Canadian Alliance on Mental Illness and Mental Health (CAMIMH) reports that 90% of Canadians believe timely access to publicly funded mental health services is crucial, while 83% see a need for more mental health care providers across provinces. Further compounding the issue, a Canadian Mental Health Association report reveals that only 15% of the new federal money is earmarked for mental healthcare. Mental health concerns continue to be a pressing issue, as studies highlight the urgent need for rapid access to care and comprehensive support systems. A study by GreenShield, a national non-profit health and benefits provider, revealed that two-thirds of Canadian employees are likely to quit their jobs due to intense stress, anxiety, and burnout. The experience is more common to women and younger workers who are 18 to 24 years old. Employees are also seeking more comprehensive mental health benefits when applying. This trend is further emphasized by a survey from Pollara Strategic Insights and Workplace Strategies for Mental Health on behalf of the Canada Life Assurance Co. and Mental Health Research Canada, which reports that 69% of employees are experiencing burnout symptoms such as lower levels of motivation, reduced levels of energy, and feelings of irritability. Mental health experts Stan Kutcher and Alexa Bagnell stress the importance of prioritizing rapid access to mental health care, especially for young people who may experience severe mental disorders. Adding to the complex picture of mental health in Canada, a study published in JAMA Network Open has shed light on the significant mental health disparities faced by transgender and gender-diverse individuals. The research reveals that transgender individuals in Canada are three times more likely to experience severe mental health disorders, such as depression and anxiety, and face significantly higher rates of suicidal thoughts and attempts compared to their cisgender peers. Lead author Heidi Eccles emphasized the critical need for enhanced support and gender-affirming care to address this mental health crisis. Senior author Dr. Ian Colman underscored the importance of these findings in informing policy decisions aimed at improving mental health services for this marginalized community. The study’s results highlight the urgent necessity for targeted interventions and comprehensive support systems to address the unique mental health challenges faced by transgender and gender-diverse Canadians, calling for immediate action from healthcare providers and policymakers alike. Book a free consultation today to learn more about how these healthcare trends might impact your organization or community.
The Importance of Full-Spectrum Monitoring: A Case in Point from the Ontario Pharmacy Consultation
The Importance of Full-Spectrum Monitoring: A Case in Point from the Ontario Pharmacy Consultation There probably isn’t a day that goes by when our monitoring doesn’t bring something important across my desk that is vitally important to one of our subscribers but isn’t being reported by the news. And it’s understandable. Not every piece of regulatory information, new consultation, or policy change will make headlines. But for those of us working in government affairs, it’s these smaller, seemingly unnoticed developments that can have the biggest impact on our work. This is a prime example. Right now, there are several consultations underway that should be of interest to those in the healthcare sector, but today I want to focus on the Ontario pharmacy consultation, sweeping in its scope. This ongoing consultation, which closes on October 20th, is looking at the potential expansion of the pharmacists’ scope of practice in Ontario. It’s an important moment for those of us in the life sciences, as it touches on areas like: • Expanding prescribing authority for pharmacists, particularly in managing chronic diseases.• Reviewing the MedsCheck program, which supports medication reviews for patients, with the possibility of expanding it to include those on fewer prescriptions.• Increasing the list of vaccines pharmacists are authorized to administer, which would have a positive impact on public health. Beyond What’s ListedWhile the government’s consultation covers several key areas, there’s also an opportunity to look beyond what’s specifically mentioned. Since 2019, pharmacists have been allowed to administer certain therapeutics by injection, but the list of approved drugs has not been updated since then. In that time, Health Canada has approved a number of new, important therapeutics, many of which remain out of reach for pharmacists to administer. For example, long-acting injectable therapies—including those for HIV, opioid use disorder, RSV, COVID-19, asthma, and immunological diseases—can provide new options for some patients. Yet, without modifications to the list of approved therapies pharmacists can administer, we may be missing out on opportunities to facilitate better access. Now, not all of these therapies may be appropriate for administration in a pharmacy setting, but proper consideration should be given to expanding the pharmacists’ role and improving access for patients across Ontario, especially those in underserved or hard-to-reach areas. Why Engagement Is CrucialFor stakeholders in healthcare and life sciences, engaging in this consultation is critical. These regulatory changes may not be front-page news (or “any page” news, for that matter), but they can significantly impact patient care and market access strategies. If you’re involved in pharmaceutical development, healthcare delivery, or patient advocacy, this consultation represents an opportunity to ensure that pharmacy practice evolves in a way that maximizes benefits for all. At Delphic Research, we’ve already prepared our submission which touches on several areas, and which offers both important context and considerations that should be kept in mind for government. If you’re interested in seeing our submission, feel free to reach out, and we’d be happy to share it with you. This consultation is a key moment for the evolution of pharmacy practice in Ontario, and I encourage everyone in this space to submit their feedback before the October 20th deadline. You can find more information and submit your feedback here.
Weekly Top Stories: Pharmacare will be paid for through a public drug plan, according to Holland
This week has been full of heated debates over the future of Pharmacare. From alarming workforce shortages to urgent calls for reconciliation, the healthcare sector is facing unprecedented pressures on multiple fronts. The Pharmacare debate has intensified with Federal Minister Mark Holland’s recent declaration that the program will be a “universal, single-payer, first-dollar coverage plan.” In a letter to the Standing Senate Committee on Social Affairs, Science and Technology, Holland outlined that Canadians in participating provinces and territories may receive free diabetes and contraceptive medications, and the cost will be charged entirely to the public drug plan. The Canadian Life and Health Insurance Association swiftly responded, claiming Holland’s statement contradicted his previous testimony in the House and Senate. The association raised concerns about the uncertainty of Pharmacare’s impact on over 27 million Canadian workers and called on lawmakers to “take the time needed to get Bill C-64 right.” Adding to the debate, the Canadian Medical Association Journal published a letter by Chris Bonnett, describing publicly funded single-payer drug plans as impractical and advocating for the necessity of private insurance in Pharmacare. According to Bonnett, using mixed-payer models with a strong regulatory framework and governance may mitigate the risk to the federal government and the public. While policymakers grapple with a coverage plan, a troubling trend has emerged in emergency care. Up to 40% of Canadians reported skipping emergency room visits last year due to lengthy wait times, prompting urgent calls for improved hospital staffing. Advocates emphasize a “Respect, Retain, Recruit”approach to address this crisis. Simultaneously, the challenges facing Canada’s healthcare workforce have come into sharp focus. A report by three Canadian senators revealed a looming shortfall of over 50,000 family doctors by 2031, advocating for increased funding to train international medical graduates (IMG) to address this crisis. The proposal suggests adding 750 family physicians annually through expanded residency training and an assessment program for IMGs, requiring a $104 million investment from 2024 to 2025. Currently, 6.5 million Canadians lack a family doctor, a number projected to rise, leading to worse health outcomes and increased emergency room reliance. The report emphasizes the urgent need for systemic changes to effectively utilize the 13,000 IMGs who are currently unable to practice in Canada. In addition to this, new research from Workplace Strategies for Mental Health, supported by Canada Life, revealed that while burnout among Canadian workers has decreased from 35% in December 2021 to 24% today, it remains a pressing issue. The study highlights that 69% of workers are experiencing symptoms that could lead to burnout, with healthcare workers reporting the highest rates at 38%. Experts urge employers to continue implementing proactive strategies to alleviate workplace stressors and prevent burnout, emphasizing the importance of early intervention and available resources, including free virtual workshops on managing workloads and stress. Another interesting report from the Montreal Economic Institute highlighted a trend in Canada’s healthcare system. It revealed that 40% of nurses trained in 2022 left the profession before turning 35, a 25% increase in young nurse departures since 2013. As Canada anticipates a shortage of 117,600 nurses by 2030, experts stress the need for improved workplace flexibility to enhance retention, particularly in Ontario, where the departure rate has surged 83% over the last decade. Amidst these challenges, efforts towards reconciliation in healthcare are gaining momentum. The Canadian Medical Association (CMA) has unveiled the first stages of its ReconciliACTION plan. In a statement, CMA President Dr. Joss Reimer reiterated the organization’s commitment to implement the plan, which was developed in collaboration with Indigenous leaders to advance Indigenous health equity. The CMA recently apologized to First Nations, Inuit, and Métis Peoples for systemic racism in healthcare. Associate Professor Marcia Anderson, an Indigenous cultural safety and anti-racism advocate from the University of Manitoba Health Sciences faculty, regarded the CMA’s apology as meaningful for addressing the divide between the public and the medical profession as she reflected on her experiences with racism in the medical system. A recent report from the British Columbia First Nations Health Authority revealed a troubling drop in life expectancy for Indigenous people in the province, decreasing by over six years between 2017 and 2021, now standing at 67.2 years compared to 82.5 years for non-Indigenous individuals. Dr. Danièle Behn Smith, B.C. Deputy Provincial Health Officer for Indigenous Health, called for systemic changes in healthcare, including increased representation of Indigenous healthcare professionals and decision-makers. Whether you’re a healthcare professional, policymaker, or concerned citizen, understanding these developments is key to contributing to the ongoing dialogue about the future of healthcare in Canada. At Delphic Research, we remain committed to bringing you the latest insights to help you navigate this rapidly changing landscape. Book a free consultation today!
Why Canada Hosting This Year’s MedTech Conference Matters
Why Canada Hosting This Year’s MedTech Conference Matters In just a couple of weeks, Toronto will play host to one of the most important medical technology conferences on Earth. The international MedTech Conference (October 15-17) will see thousands of participants from across North America and beyond come together to learn, grow, share, and celebrate the accomplishments of the sector. This year, the conference is being held on Canadian soil for the first time, a significant moment that reflects the increasing maturity and depth of Canada’s MedTech sector. Without a doubt, this is a testament to the hard work of so many within Canada’s vibrant life sciences and medical device sector and, in particular, the great leadership of Medtech Canada, its board, and Nicole DeKort in putting Canada’s MedTech sector on the global map. Medical technology is an incredibly diverse category, encompassing a wide range of innovations that differ in their application, use, and placement within healthcare systems. From diagnostic tools and surgical devices to advanced prosthetics and health monitoring systems, the landscape is rich with variety and opportunity. Because of this diversity, the issues facing the industry can be quite varied as well, depending on the technology in question. However, there are several regulatory and policy trends that affect the sector as a whole, are in constant motion, and require careful attention: The Circular Economy/Extended Producer Responsibility The push towards a circular economy is placing new obligations on manufacturers and first importers in terms of the full lifecycle of their products and packaging. This movement has been gaining momentum for years, particularly within other industries such as consumer packaged goods. However, we are now seeing its application to the MedTech sector, where manufacturers must prepare to take greater responsibility for sustainability and stewardship across the product lifecycle. This has meant new obligations and new costs being borne by the sector, driven primarily by provincial regulations and approaches which are not always aligned when it comes to product stewardship. And, while industry would benefit from greater coordination, alignment, and certainty among provincial governments, this remains an area of policy that requires one to keep track of what is happening in each jurisdiction, among stewardship organizations, and the activities of stakeholders within this developing area of responsibility. Right to Repair The right to repair movement continues to advance, with policy and legislative developments at both the federal and provincial levels in Canada, and with implications for the medical device space. While the “right to repair” movement is largely rooted in consumer electronics and other household goods, steps taken by policymakers have broadened the circle through measures that would impact on the highly regulated world of medical devices with potential implications for patients, health delivery organizations, and industry. This movement is creating new expectations for device manufacturers with respect to access to repair parts to extend the life of medical devices, as well as changes to copyright legislation that interfere with manufacturers’ abilities to use digital locks to protect the integrity and safety of their codebase. These expectations, however, are not without their risk to patients and to healthcare delivery organizations, something which our existing medical device regulatory regime is designed to protect. Consequently, it is vitally important that policymakers engage the industry and its representatives in meaningful consultations throughout every stage on every element of policy when it comes to these changes. For its part, the medical device sector must continually monitor this issue and adapt to what feels like a constantly evolving regulatory and policy landscape, even as it tries to influence future directions towards a more balanced path. Canada-U.S.-Mexico Agreement (CUMSA/USMCA) Review/Renegotiation The pending review and possible renegotiation of the trade agreement among North America’s “Three Amigos” (Canada-US-Mexico) could have a major impact on the MedTech sector (and our economy more broadly), with implications for tariff policy, intellectual property protection, and the free movement of both parts and fully assembled products. Understanding the implications of potential changes in trade policies is crucial for companies as they navigate market access, pricing, and supply chain management. Understandably, the outcome of the US election will have a major impact on trade policy in the years to come. Facilitating Better Access to Medical Device Innovation Medical device innovation able to provide huge benefits to both patients and health systems but the pace of adoption in healthcare lags the pace of innovation itself. For all our sakes, this is an issue that needs to be addressed. Unlike pharmaceutical reimbursement pathways, medical devices and other health technologies often face more complex — or at least far less defined – avenues for market access. Without losing sight of what makes them different from medicines, it is important to acknowledge that barriers exist when it comes to the adoption of innovative technologies in healthcare settings. Policy makers should consider strategies that facilitate earlier adoption of new medical technology, including the option of providing direct funding support to accelerate the adoption of these new technologies by health delivery organizations. During MedTech 2024, Delphic Research will be looking to help raise the profile of this essential sector and ensure that its contributions to our health are recognized and supported. There has never been a more exciting time to be involved in MedTech, and I am confident that the discussions we have at this conference will help shape the future of healthcare in Canada and beyond. If you would like to learn more about this year’s MedTech Conference, please click here.
Weekly Top Stories: Pharmacare Could Threaten Economy, Says Drug Industry
In this week’s edition, we witness the heated Pharmacare debate that’s dividing industry stakeholders and unions, and the quiet revolution in dental care access sweeping across communities, our healthcare landscape surely is evolving at a dizzying pace. The Canadian healthcare system finds itself at a critical juncture, with the proposed Pharmacare program at the centre of a heated debate between industry stakeholders, public sector unions, and a public increasingly concerned about access to medical care. According to an article published in The Globe and Mail, major stakeholders in the drug industry warned that Pharmacare may threaten the “economic balance” between manufacturers, retailers, and insurance companies. Canadian Life and Health Insurance Association President Stephen Frank expressed that Pharmacare could pose “risk and uncertainty” to existing coverage. More specifically, University of British Columbia Research Chair Dr. Michael Law claimed that the bill could incentivize benefit sponsors to reduce coverage for diabetes and contraceptive medications, while forcing Canadians to file claims through public instead of private plans. In addition to this, the Neighbourhood Pharmacy Association of Canada stands to lose $43 million in annual revenue if a universal public plan is implemented. Advocating for a mixed-payer approach, Loblaw Cos. Ltd and Shoppers Drug Mart have conducted over 22 lobbying activities since Pharmacare was introduced. At the same time, Canadian Generic Pharmaceutical Association President Jim Keon expressed the need for more clarity to inform manufacturing decisions.In stark contrast, public sector unions and advocacy groups are rallying for swift implementation of Pharmacare. The National Union of Public and General Employees (NUPGE) urged parliamentarians to prioritize Canadians’ well-being by resisting Conservative leader Pierre Poilievre’s push for an immediate election, which they claim threatens the progress of critical measures like the new Pharmacare legislation. NUPGE President Bert Blundon emphasized that halting parliamentary work would jeopardize essential support for Canadians struggling with high medication costs, asserting that the Pharmacare Act is a vital step toward improving the healthcare system and must be enacted without delay. The Avalon Chapter of the Council of Canadians called on the provincial government to commit to the national pharmacare program as the Pharmacare Act nears Royal Assent. In an open letter delivered to the premier and health minister, they emphasized the importance of ensuring that all residents with a Medical Care Plan card can access prescription contraceptives and diabetes medications without out-of-pocket costs, coinciding with the upcoming World Contraception Day of Action. This debate is unfolding against a backdrop of growing public dissatisfaction with the current healthcare system. A recent survey by Navigator revealed that nearly half of Canadians feel their access to medical care has declined. This perception has opened the door to discussions about healthcare reform, with many Canadians open to a larger role for the private sector. However, concerns about private payments remain, with fears they may favour wealthier individuals. Advocacy groups demand government action to address surgical backlogs and enhance public healthcare. While the Pharmacare debate continues, another healthcare initiative is showing promising results. The Canadian Dental Care Plan (CDCP) is making significant strides in improving oral health access across the nation, with over 750,000 Canadians recently accessing dental care services. Health Minister Mark Holland emphasized the government’s commitment to expanding dental services and improving accessibility, particularly for underserved populations, as part of a broader initiative to enhance overall health outcomes across the nation. However, the Conservatives oppose the CDCP for Quebecers, despite the evident need for dental services among hundreds of thousands in the province. This stance continues even as many of their constituents are enrolling in the program, raising concerns about access to essential dental care. Over 2.4 million Canadians have enrolled in the CDCP, with 750,000 already receiving services. This achievement marks a significant milestone for improving oral health and overall well-being across the country. Amidst these ongoing healthcare debates and initiatives, Research Canada has unveiled its 2024 Leadership in Advocacy Award recipients, celebrating outstanding contributions to health research advocacy in the country. Dr. Leena Augimeri was honoured for her impressive four-decade career dedicated to child and youth mental health and crime prevention, highlighting the long-term impact of committed researchers in shaping healthier communities. JDRF Canada received recognition for its tireless advocacy in type 1 diabetes research, underscoring the crucial role that patient-focused organizations play in driving medical advancements. In a nod to the future of health research advocacy, Kaitlin Kharas was presented with the inaugural Emerging Leader in Advocacy Award for her influential work in shaping Canadian policies that support graduate students and postdoctoral researchers. These developments are not just reshaping the health sector; they’re sending ripples through industries far and wide, making it imperative for leaders across all sectors to stay informed and agile. Stay informed with Delphic Research, book a free consultation today!
Weekly Top Stories: Health Minister Mark Holland pushes Senate to pass Pharmacare without amendments
In this week’s edition, we cover urgent pushes for programs to innovations and sobering reflections on systemic issues. The healthcare landscape is evolving rapidly, and it is important that we keep an eye on developments that can affect not only us but also our industries. In a crucial move at the federal level, Health Minister Mark Holland is pressing the Senate to pass Bill C-64, the Pharmacare bill, without amendments. On September 18, Holland appealed to the the Senate Social Affairs, Science, and Technology Committee, emphasizing the bill’s complexity and urgency. Stemming from the now-defunct supply-and-confidence deal between the Liberal government and the New Democratic Party, the bill is set for a third reading vote on October 10. If passed, Holland will enter negotiations with provinces and territories to provide coverage for diabetes and contraceptive medications. In addition to this, the Council of Canadians submitted a briefing note to the Standing Senate Committee on Social Affairs, Science andTechnology, detailing its three recommendations on Pharmacare. The council echoed Holland’s call to pass the bill without tweaks, citing the immediate need for timely rollout. Additionally, the council proposed to attach observations to affirm a public, single-payer, universal drug plan and guard against conflicts of interest throughout the policy-making process. Meanwhile, Ontario is considering expanding pharmacists’ duties to include more minor ailments, such as sore throat and shingles, additional vaccines, and some lab tests, according to Global News. While pharmacists support the change as a means to alleviate pressure on the healthcare system, doctors, represented by the Ontario Medical Association, express concerns about the impact on care quality arguing that doctors are better trained to handle complex conditions. At the same time, the Ontario Pharmacists Association dismisses safety concerns as the government considers adding more ailments to pharmacists’ responsibilities. A recent Blue Cross study has revealed interesting trends in Canadians’ approach to health. While 72% of Canadians have attempted to improve their health over the past year, particularly among younger generations, nearly half, or 48%, are not seeking professional health support due to perceived barriers. This disconnect highlights a significant challenge in healthcare utilization. Across the country, provinces are addressing various healthcare issues with targeted initiatives. Newfoundland and Labrador has launched a website to support dementia patients and caregivers, backed by $3.5 million in annual funding. It provides resources on diagnosis, treatment options, and training for businesses to create more inclusive environments for those affected by dementia, addressing the needs of the province’s aging population, which currently has about 10,000 diagnosed individuals. Saskatchewan is set to introduce its first Interventional Tricuspid Valve Repair Program in 2025, investing $330,000 annually for specialized procedures at the Royal University Hospital in Saskatoon. Manitoba is improving access to primary care with its first Extended Hours Primary Care Clinic at Grace General Hospital. All of these in the hopes that this will help improve our healthcare system. While these provincial initiatives aim to address current healthcare challenges, the medical community is also taking steps to rectify historical injustices. The Canadian Medical Association (CMA) drew praise after formally apologizing for its role in the historical and ongoing mistreatment of Indigenous Peoples, acknowledging systemic racism and substandard care. In an opinion piece, The Globe and Mail health columnist André Picard said the CMA’s pledge to work collaboratively with Indigenous communities is the right way to pursue reconciliation, citing its ReconciliACTION plan to rebuild trust and improve healthcare. The path forward requires a delicate balance of efficiency, quality of care, and equity. As our healthcare landscape continues to evolve rapidly, staying informed about these changes is crucial not only for healthcare professionals but for all Canadians and industries affected by health policy decisions. Delphic Research’s Executive Daily Briefing can be your tool to navigate these complex developments, ensuring that you are always ahead of the curve. Book a free consultation today!
Weekly Top Stories: Canada’s Healthcare System Navigates Through Crises and Policy Shifts
Political shifts and policy changes continue to shape our healthcare system. As we witness these developments unfold, it is crucial to remain not just spectators but informed and engaged citizens. The challenges we face today demand our attention and understanding, for it is through awareness that we can hope for and contribute to meaningful solutions. Across the nation, provinces are facing unique healthcare hurdles. In Ontario, an Ontario Council of Hospital Unions report warned of a looming hospital crisis in the province, with expected shortages of 13,800 beds and over 80,000 staff by 2032. It also noted longer wait times and rising vacancies, citing insufficient funding and increased demand as key issues. Alberta also continues to grapple with workforce issues as the United Nurses of Alberta enters mediation sessions with employers to discuss issues including wages, benefits, and workforce stability. Meanwhile in Quebec, the provincial government will begin granting advance requests for medically assisted death (MAID) from October 30, bypassing the need for federal changes to the Criminal Code. This decision follows the province’s announcement last month to move ahead with the plan, allowing individuals to arrange MAID while still capable of consent. Newfoundland and Labrador focuses on enhancing radiation safety standards. The new Radiation Health and Safety Act and updated regulations will take effect on December 2, 2024, enhancing safety standards for radiation equipment and formalizing procedures for its operation and installation. The regulations will also allow dental hygienists to order, prescribe, and provide radiography services starting December 2. The provincial government is expanding virtual urgent care services in Central Newfoundland by launching new offerings at the Bay D’Espoir Medical Clinic in St. Alban’s starting September 11. The expansion offers remote consultations with nurse practitioners and local health professionals to manage non-emergent medical issues. A glimmer of hope emerges from London, Ontario, where researchers have made a breakthrough as they detected signs of awareness in a comatose patient using functional near-infrared spectroscopy (fNIRS), suggesting that some unresponsive patients may still have cognitive awareness. In British Columbia, mental healthcare reform takes centre stage, with Premier David Eby advocating for more humane involuntary mental healthcare practices and has appointed Dr. Daniel Vigo to create a new strategy following a recent violent incident in Vancouver and criticism over the 2012 closure of Riverview Mental Health Hospital. These challenges unfold against a backdrop of shifting federal policies. In the wake of the terminated NDP-Liberal agreement, Health Minister Mark Holland has reaffirmed that the Liberal government will still support measures including Pharmacare and the Canadian Dental Care Plan (CDCP). In a news conference at the University of Toronto, Holland declared that over 650,000 Canadians have benefited from the CDCP, with an 80% participation rate from dentists and dental hygienists. The health minister expressed continuous support for measures that have yet to be tabled, including the Safe Long-Term Care Act. An opinion piece published in Hill Times criticized the NDP and Liberals’ “corporate-friendly” Pharmacare, citing disbelief at Singh’s concern over prioritizing public interest. Writers Steve Morgan, Matthew Herder, and Nav Persaud described the present drug coverage plan as a “fill-the-gaps” corporate handout that will further increase drug prices, similar to Quebec’s system in 1997. As we continue to navigate through these challenges, the scientific community is laying the groundwork for the future of Canadian healthcare. The Royal Society of Canada Working Group on Health Research System Recovery has proposed comprehensive recommendations to enhance the country’s health research system in the post-pandemic era. The report emphasized better emergency preparedness, increasing equity, rethinking funding, and boosting researcher support based on input from global and Canadian experts. Education, too, plays a crucial role in shaping the future of healthcare. A virtual course based on the Canadian Institutes of Health Research’s patient-oriented research strategy has successfully trained 189 participants across Canada, helping them overcome challenges like distance and scheduling. Feedback from learners and facilitators highlighted satisfaction with the course’s co-learning elements, with minor adjustments planned to enhance accessibility and improve future iterations. At Delphic Research, we are committed to illuminating the complex terrain of healthcare issues. Our weekly top stories can serve as your compass through the intricacies of developments, ensuring you’re well-equipped to comprehend and respond to the changing reality around us. We offer daily briefings to help you navigate this evolving healthcare landscape. Book your free consultation today and be prepared for whatever comes next in Canadian healthcare.
Weekly Top Stories: NDP Ends ‘Supply and Confidence Agreement’ with Liberals
This week, a shift in Canadian politics threatens to reshape healthcare policies, even as new initiatives launch and reports highlight persistent challenges in the system. The New Democratic Party (NDP) has terminated its Supply and Confidence Agreement with Prime Minister Justin Trudeau’s Liberal Party, potentially destabilizing Canada’s political and healthcare landscape. NDP leader Jagmeet Singh cited the Liberals’ perceived weakness and alignment with corporate interests as reasons for ending the agreement. This development could lead to significant changes, including the possibility of an early election before the scheduled October 2025 date. The agreement, which began in 2022 and was set to last until June 2025, had facilitated major public healthcare expansions. The agreement outlined key priorities for improving the Canadian healthcare system, such as launching a new dental care program for low-income Canadians, expanding it to cover more groups by 2025, and advancing towards a universal pharmacare program with the Canada Pharmacare Act. With this, the NDP will now vote on Liberal bills individually, with key upcoming tests including an economic update and the federal budget implementation bill. This shift could significantly impact the pace and direction of healthcare reforms in Canada. Conservative leader Pierre Poilievre has called for what he termed a “carbon tax election” following the NDP’s withdrawal of support from the Liberal government. Poilievre criticized Singh and argued that the end of the agreement should prompt an election focused on opposing the carbon tax. The move reflects heightened political tensions and the potential for a federal election sooner than scheduled. While Government House Leader Karina Gould expressed surprise at learning of Singh’s decision via social media, calling the move “odd” and questioning its timing, Saskatchewan NDP leader Carla Beck, welcomed the end of the agreement, citing frustrations with the lack of meaningful results. Following Singh’s announcement that his party is ending the agreement with the Liberals, Trudeau expressed hope that the NDP remains focused on serving Canadians rather than engaging in political disputes. Amidst this political uncertainty, Trudeau honoured Canadian workers on Labour Day, September 2, 2024. He praised their role in building the middle class and highlighted government actions like fair wages, affordable childcare, and healthcare reforms. He also reaffirmed the government’s ongoing support for workers and their contributions to the country’s progress. Despite the political turbulence, progress in healthcare initiatives continues. Canada’s Drug Agency (CDA) has officially launched, broadening its role to include new programs focused on drug use, data analytics, and system coordination, following extensive consultations with patients, clinicians, and other stakeholders. The Appropriate Use Advisory Committee welcomed 10 new members, including Julia Bareham and Dr. Devin Harris, who bring extensive expertise in appropriate use, implementation science, and health policy. They will join co-chairs Stephen Samis and Dr. Jim Silvius in their mission to enhance prescribing practices and medication use across Canada, with their inaugural meeting scheduled for this month. On September 10, 2024, CDA will present expert guidance on evidence-informed and equitable aging-in-place policies, featuring insights from the Health Technology Expert Review Panel and Healthcare Excellence Canada on its implications for health and social service organizations. Still, challenges persist, as highlighted by a new report from the Canadian Institute for Health Information (CIHI). The report revealed that nearly 15.5 million unscheduled emergency department visits occurred in Canada between April 2023 and March 2024, with abdominal and pelvic pain being the most common reason accounting for over 444,000 cases. Hospital-admitted patients experienced longer ED stays, with 90% completing their visits within 48 hours, while urinary system disorders led to the longest average visits at 12.3 hours. In times of rapid change, expert analysis becomes invaluable. Delphic Research offers daily briefings to help you navigate the evolving healthcare landscape. Book your free consultation today and ensure you’re prepared for whatever comes next.
Weekly Top Stories: UN Report Criticizes Canada’s Temporary Foreign Worker Program as Healthcare Challenges Persist
In this edition, you will see how Canada’s healthcare practices were thrust into the international spotlight. The nation continues to grapple with challenges ranging from the treatment of foreign workers in the country to the future of long-term care. A United Nations report has sharply criticized Canada’s Temporary Foreign Worker Program, highlighting significant healthcare access barriers and describing conditions similar to modern “slavery”. UN Special Rapporteur Tomoya Obokata emphasized that temporary foreign workers in Canada face significant obstacles in accessing healthcare, citing inadequate coverage and the risk of employer retaliation. In a related development, The Globe and Mail reported on a new initiative aimed at improving communication and providing retired physicians with volunteer opportunities. The Health English Language Pro (HELP) program, set to launch in September, will connect Canadian doctors with foreign-trained health professionals to assist them in learning medical English and integrating into the Canadian health system. On the domestic front, the Canadian Oral Health Survey revealed that approximately 72% of Canadians aged 12 and older visited an oral health professional between November 2023 and March 2024, a rebound from 65% in 2022 but slightly below the 75% reported in 2018. The survey, Canada’s first national oral health assessment, also highlighted disparities in dental insurance coverage, with significant differences in access to care based on age, insurance status, and regional location. In response to ongoing healthcare challenges, the federal government has announced a $3.2 million investment from the Intersectoral Action Fund (ISAF) to support 16 new community projects across Canada aimed at improving health equity and addressing social determinants of health. The Canadian Centre for Housing Rights received $248,950 to tackle homelessness risk for people leaving healthcare facilities, and the Canadian Mental Health Association got $195,148 to enhance harm reduction and anti-racism in Toronto’s supportive housing. Additional projects include a bilingual rights data repository for older adults in Fredericton and a coalition against conversion therapy in Burnaby. Looking towards the future of healthcare policy, Health Canada has released a comprehensive report summarizing feedback from public consultations on the proposed Safe Long-Term Care Act, which aims to enhance access to quality, safe, and equitable long-term care in Canada. The report reflected the perspectives of over 5,000 participants, emphasizing the preference for aging at home with necessary supports and highlighting priorities such as diversity, workforce support, and increased transparency in long-term care. The interplay between international scrutiny, national initiatives, and evolving public health needs underscores the importance of staying informed and prepared for rapid changes in the healthcare landscape. Do you still think you do not need our Executive Daily Briefings? Book a free consultation today with Delphic Research.
Weekly Top Stories: Higher Food Insecurity Rates Among Canadians with Disabilities; and the True Cost of Public Healthcare
This week in Canadian healthcare brings to light critical issues affecting vulnerable populations, alongside ongoing debates about pharmacare and rising healthcare costs. A Health Reports study released on August 21, 2024, revealed alarming rates of food insecurity among Canadians with disabilities. Over one in four individuals with disabilities faced household food insecurity in 2021, significantly higher than the 12.5% prevalence among those without disabilities. The study highlighted that individuals with learning, memory, cognition, or seeing disabilities experienced the highest rates of food insecurity, with severe levels affecting 8% of those with disabilities compared to 2% of those without. The report also noted that Indigenous individuals, the unemployed, and those in lower income brackets with disabilities faced particularly high levels of severe food insecurity, even when accounting for income and employment factors. Concurrently, a new Fraser Institute study estimated that a typical Canadian family of four will pay approximately $17,713 for public healthcare insurance in 2024 through various taxes despite the system being perceived as “free.” The report, authored by Nadeem Esmail, highlighted that many Canadians are unaware of these costs, as they are not directly billed for medical services but instead fund the system through general taxes and employer contributions. The study emphasized the often-overlooked financial burden of public health care on Canadian households. In another policy development, the federal Liberal-NDP coalition government has unveiled plans to implement the initial phase of a national pharmacare program, starting with universal prescription drug benefits for contraceptives and diabetes medications. However, a study by the Canadian Health Policy Institute has raised concerns about the current public drug plans, Canadians have access to significantly fewer new drugs and face longer wait times compared to those with private insurance. The study showed that, on average, public drug plans covered only 18% of new drugs authorized by Health Canada from 2018-2022, with a wait time of over two years, while private plans covered 64% with an average wait time of 369 days. These findings suggest that the transition to national pharmacare could potentially reduce access to new medicines for the 27 million Canadians currently covered under private plans. Further highlighting challenges in the healthcare system, Dr. Nigel Rawson and Dr. David Stewart published an article in Canadian Health Policy emphasizing that the benefit of expedited regulatory approval for oncology drugs in Canada is undermined by slow reimbursement reviews and prolonged price negotiations, often delaying patient access by up to three years. The authors analyzed 92 oncology drugs and found that government procedures significantly extend the time between regulatory approval and final access to treatment. Amidst these concerns, Prime Minister Justin Trudeau tabled the Thirty-First Annual Report on the Public Service of Canada in the House of Commons on August 21, 2024. The report highlighted the public service’s role in advancing housing, healthcare, climate change, and reconciliation with Indigenous Peoples. The report, presented by Clerk of the Privy Council John Hannaford, also emphasized efforts to promote diversity and adapt to new challenges like artificial intelligence. The intersection of food insecurity, rising costs, pharmacare debates, and access to new treatments paints a complex picture of a system under pressure. Yet, it also presents opportunities for meaningful reform and innovation. Grab your very own Executive Daily Briefing today, book a free consultation with Delphic Research!